Tangmere TDMP Holding Limited 15935760 false 2024-09-04 2025-07-31 2025-07-31 The principal activity of the company is that of a holding company. Digita Accounts Production Advanced 6.30.9574.0 true false true false 15935760 2024-09-04 2025-07-31 15935760 2025-07-31 15935760 core:RetainedEarningsAccumulatedLosses 2025-07-31 15935760 core:ShareCapital 2025-07-31 15935760 core:CurrentFinancialInstruments 2025-07-31 15935760 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 15935760 core:Non-currentFinancialInstruments core:AfterOneYear 2025-07-31 15935760 core:AdditionsToInvestments 2025-07-31 15935760 bus:SmallEntities 2024-09-04 2025-07-31 15935760 bus:AuditExemptWithAccountantsReport 2024-09-04 2025-07-31 15935760 bus:FilletedAccounts 2024-09-04 2025-07-31 15935760 bus:SmallCompaniesRegimeForAccounts 2024-09-04 2025-07-31 15935760 bus:RegisteredOffice 2024-09-04 2025-07-31 15935760 bus:Director1 2024-09-04 2025-07-31 15935760 bus:Director2 2024-09-04 2025-07-31 15935760 bus:Director3 2024-09-04 2025-07-31 15935760 bus:Director4 2024-09-04 2025-07-31 15935760 bus:PrivateLimitedCompanyLtd 2024-09-04 2025-07-31 15935760 bus:Agent1 2024-09-04 2025-07-31 15935760 core:Subsidiary1 2024-09-04 2025-07-31 15935760 core:Subsidiary1 1 2024-09-04 2025-07-31 15935760 1 2024-09-04 2025-07-31 15935760 countries:AllCountries 2024-09-04 2025-07-31 iso4217:GBP xbrli:pure

Registration number: 15935760 (England and Wales)

Prepared for the registrar

Tangmere TDMP Holding Limited

Annual Report and Unaudited Financial Statements

for the Period from 4 September 2024 to 31 July 2025

 

Tangmere TDMP Holding Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Tangmere TDMP Holding Limited

Company Information

Directors

Dr S P Chaplin-Rogers

T J Chaplin-Rogers

N H R Forster

Dr P D Liano

Registered office

Park Surgery
Hursley Road
Chandler's Ford
Hampshire
SO53 2ZH

Accountants

Hazlewoods LLP Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Tangmere TDMP Holding Limited

(Registration number: 15935760)
Balance Sheet as at 31 July 2025

Note

2025
£

Fixed assets

 

Investments

4

815,194

Current assets

 

Debtors

5

89,760

Creditors: Amounts falling due within one year

6

(91,200)

Net current liabilities

 

(1,440)

Total assets less current liabilities

 

813,754

Creditors: Amounts falling due after more than one year

6

(842,008)

Net liabilities

 

(28,254)

Capital and reserves

 

Called up share capital

1

Retained earnings

(28,255)

Shareholders' deficit

 

(28,254)

For the financial period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 21 July 2026 and signed on its behalf by:
 


T J Chaplin-Rogers
Director

 

Tangmere TDMP Holding Limited

Notes to the Unaudited Financial Statements for the Period from 4 September 2024 to 31 July 2025

 

1

General information

The company is a private company limited by share capital, incorporated in the United Kingdom.

The address of its registered office is:
Park Surgery
Hursley Road
Chandler's Ford
Hampshire
SO53 2ZH

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Disclosure of long or short period

The financial statements cover a period of 331 days. This is to bring the year end in line with that of the rest of the group.

Going concern

Not withstanding the net liability position shown on the balance sheet, the financial statements have been prepared on the going concern basis. The directors have considered the forecast cash flows and the cash requirements of the business in their assessment of going concern. As a result of this assessment it was concluded that the cash requirements of the business for the 12 months from signing will be met through a combination of operational cash flows and intergroup loans and thus the business is deemed to operate as a going concern.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements and estimation uncertainties

No significant judgements or key estimation uncertainties have been made by management in preparing these financial statements.

 

Tangmere TDMP Holding Limited

Notes to the Unaudited Financial Statements for the Period from 4 September 2024 to 31 July 2025

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 

Tangmere TDMP Holding Limited

Notes to the Unaudited Financial Statements for the Period from 4 September 2024 to 31 July 2025

Financial instruments (continued)

Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was as follows:

Subsidiaries

£

Cost and carrying amount

Additions

815,194

At 31 July 2025

815,194

 

Tangmere TDMP Holding Limited

Notes to the Unaudited Financial Statements for the Period from 4 September 2024 to 31 July 2025

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

2025

Subsidiary undertakings

Tangmere Dental Care Ltd

United Kingdom

Ordinary

100%

Subsidiary undertakings

Tangmere Dental Care Ltd

The principal activity of Tangmere Dental Care Ltd is the provision of dental care.

 

5

Debtors

Note

2025
£

Amounts owed by related parties

8

89,760

 

6

Creditors

Note

2025
£

Due within one year

 

Amounts due to group undertakings

8

89,200

Accruals

 

2,000

 

91,200

Due after one year

 

Amounts owed to group undertakings

 

842,008

 

7

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The company is bound by an intra-group cross guarantee in respect of bank borrowings in the group headed by TDMP Group Limited. The total amounts guaranteed are £12,437,520.

 

8

Related party transactions

The company has taken advantage of the exemption contained within FRS102 not to disclose transactions with companies within the same group. Balances due to and from these companies are included in debtors and creditors notes above.

 

Tangmere TDMP Holding Limited

Notes to the Unaudited Financial Statements for the Period from 4 September 2024 to 31 July 2025

 

9

Parent and ultimate parent undertaking

The company's immediate parent is TDMP Group Ltd, incorporated in the United Kingdom.

 The ultimate controlling party are the directors by virtue of their shareholdings.